ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
AnaptysBio Inc

AnaptysBio Inc (ANAB)

37.06
-0.17
(-0.46%)
Closed July 27 4:00PM
36.99
-0.07
(-0.19%)
After Hours: 7:59PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
37.06
Bid
20.00
Ask
38.00
Volume
288,205
36.89 Day's Range 38.85
13.36 52 Week Range 38.85
Market Cap
Previous Close
37.23
Open
37.71
Last Trade
1
@
37.99
Last Trade Time
Financial Volume
$ 10,807,899
VWAP
37.5007
Average Volume (3m)
313,642
Shares Outstanding
27,318,644
Dividend Yield
-
PE Ratio
-6.18
Earnings Per Share (EPS)
-5.99
Revenue
17.16M
Net Profit
-163.62M

About AnaptysBio Inc

AnaptysBio Inc is clinical-stage biotechnology company. It is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company develops product candidates to address emerging biological targets using its proprietary, antibody discovery techno... AnaptysBio Inc is clinical-stage biotechnology company. It is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company develops product candidates to address emerging biological targets using its proprietary, antibody discovery technology platform, which is designed to replicate, in vitro, the natural process of antibody generation. Its product candidates are ANB020, ANB019, and Checkpoint receptor agonist. The entity generates revenue from the collaborative research and development arrangements. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
AnaptysBio Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ANAB. The last closing price for AnaptysBio was $37.23. Over the last year, AnaptysBio shares have traded in a share price range of $ 13.36 to $ 38.85.

AnaptysBio currently has 27,318,644 shares outstanding. The market capitalization of AnaptysBio is $1.02 billion. AnaptysBio has a price to earnings ratio (PE ratio) of -6.18.

ANAB Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10037.0638.8533.6529524535.60523224CS
412.0648.242538.8523.7230438931.50561512CS
1210.338.49028400626.7638.8522.2631364226.51907218CS
2613.2155.387840670923.8538.8518.4933644624.50055559CS
5219.5111.04783599117.5638.8513.3629971421.98911593CS
15611.4144.483430799225.6538.8513.3625380623.80356296CS
260-17.44-3254.556.729.1633151322.02214518CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WINTWindtree Therapeutics Inc
$ 8.24
(150.46%)
48.57M
BFIBurgerFi International Inc
$ 0.4206
(97.37%)
313.59M
NBSTWNewbury Street Acquisition Corporation
$ 0.1349
(92.71%)
122.1k
YIBOPlanet Image International Ltd
$ 2.915
(53.43%)
260.07k
CREVCarbon Revolution Public Ltd
$ 9.00
(45.87%)
8.06M
NMHINatures Miracle Holding Inc
$ 0.2035
(-48.06%)
7.69M
TANHTantech Holdings Ltd
$ 0.2585
(-47.23%)
6.75M
DXCMDexCom Inc
$ 64.00
(-40.66%)
53.92M
PSIGPS International Group Ltd
$ 1.42
(-31.40%)
716.26k
POAIPredictive Oncology Inc
$ 1.36
(-27.27%)
6.02M
SLNASelina Hospitality PLC
$ 0.0305
(-18.88%)
408.61M
BFIBurgerFi International Inc
$ 0.4206
(97.37%)
313.59M
NVDANVIDIA Corporation
$ 113.06
(0.69%)
293.33M
SQQQProShares UltraPro Short QQQ
$ 9.10
(-2.88%)
176.49M
SGMOSangamo Therapeutics Inc
$ 0.8612
(28.15%)
123.71M

ANAB Discussion

View Posts
gfp927z gfp927z 2 years ago
HighPeaks, The NY Times article was high profile, but the connection to ANAB isn't readily apparent.

Even with the partial sale/monetization of the revenue stream from dostarlimab in December, the drug is also being studied by Glaxo for other cancer types (endometrial, non-small cell lung, ovarian, and mismatch repair deficient solid tumors). One question to answer is whether the monetization deal with Sagard was only for colorectal, or for all the indications? Probably for all, but I'll have to do more research.

ANAB has numerous other programs and a large pile of cash, so looks interesting. But investing in biotech requires a ton of research, but even then you still don't know what you have, and landmines are everywhere. Better to invest in 'what you know', as Buffett recommends :o)




---
πŸ‘οΈ0
HighPeaks HighPeaks 2 years ago
Thanks TP. Yeah this has the potential to really be a big mover. So surprised no one has made the connection between this potential miracle drug and $ANAB receiving royalties on it(as it’s originator). GSK is the collaborator who has just commercialized it but it’s ANAB invention.
πŸ‘οΈ0
tedpeele tedpeele 2 years ago
Tremendous find HighPeaks. .You have been early on quite a few big movers. I'm thinking this is yet another one.

Will be watching this closely...thanks.
πŸ‘οΈ0
HighPeaks HighPeaks 2 years ago
According to this link ANAB gets 8-25% royalties from Dostarlimab. This drug has recently shown phenomenal results in a trial at Memorial Sloan Kettering Hospital. All patients fully recovered from rectal cancer.
https://www.globenewswire.com/fr/news-release/2020/10/26/2114250/0/en/AnaptysBio-and-GlaxoSmithKline-Amend-Strategic-Immuno-Oncology-Collaboration.html
πŸ‘οΈ0
TFMG TFMG 4 years ago

$ANAB | #Anaptysbio Spikes After Drug Designation


Nice spike in the afterhours session, lets hope we
can get some continuation tomorrow.
Target $29.00 to Fib Golden Pocket
Also a very large gap to fill at $35.00
AnaptysBio gets orphan drug designation of imsidolimab for pustular psoriasis
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.


πŸ‘οΈ0
LoveItInBishop LoveItInBishop 5 years ago
RSI @ 16. laughable. Zacks has positive take. https://finance.yahoo.com/news/anaptysbio-enters-oversold-territory-135501475.html
πŸ‘οΈ0
ClayTrader ClayTrader 5 years ago
* * $ANAB Video Chart 11-13-19 * *

Link to Video - click here to watch the technical chart video

πŸ‘οΈ0
ClayTrader ClayTrader 5 years ago
* * $ANAB Video Chart 11-08-19 * *

Link to Video - click here to watch the technical chart video

πŸ‘οΈ0
waterchaser waterchaser 5 years ago
LOL! Twitter PnD. Buyer beware.
πŸ‘οΈ0
420man 420man 5 years ago
Once the real bounce starts it will be fast....
πŸ‘οΈ0
Crazy Money Crazy Money 5 years ago
$10 to da moon
πŸ‘οΈ0
420man 420man 5 years ago
This will bounce..... 15 AH
πŸ‘οΈ0
RJ Trotts RJ Trotts 5 years ago
trying to bounce back over $11, hoping for more
πŸ‘οΈ0
TaxiCaT TaxiCaT 5 years ago
Ouch -
πŸ‘οΈ0
celle celle 5 years ago
Nothing happen here?
πŸ‘οΈ0
manny371 manny371 7 years ago
This stock is making noise! Bought in Sept $ANAB
πŸ‘οΈ0